[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338586-105":59,"doc-detail-338586-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-systematic-review-of-the-molecular-mechanisms-involved-in-the-association-between-pcos-and-endometrial-and-ovarian-cancers","A Systematic Review of the Molecular Mechanisms Involved in the Association Between PCOS and Endometrial and Ovarian Cancers","","Polycystic ovary syndrome (PCOS) is a major cause of female infertility affecting 4%–20% of reproductive-age women. Metabolic and hormonal alterations in PCOS may increase the risk of endometrial cancer (EC) and ovarian cancer (OVCA). This systematic review summarizes proposed molecular mechanisms linking PCOS to EC or OVCA, using a literature search for studies published in English from 2010 to December 2022. PRISMA guided selection, PROSPERO registration used CRD42022375461, and QUADAS-2 and Review Manager assessed quality and bias. Forty-five studies identified genomic, transcriptomic, metabolomic, proteomic and epigenetic molecular signatures. Deregulated EC/OVCA genes overlapping in PCOS included BRCA1, MLH1, NQO1 and ESR1. Additional PCOS-related biomarker signals included serum IGF1, IGFBP1, SREBP1, visfatin, and salusin-β for increased OVCA risk. Gene signature–based drug repositioning highlighted candidates such as metformin, fenofibrate, fatostatin, melatonin, resveratrol and quercetin.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-systematic-review-of-the-molecular-mechanisms-involved-in-the-association-between-pcos-and-endometrial-and-ovarian-cancers/338586/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-systematic-review-of-the-molecular-mechanisms-involved-in-the-association-between-pcos-and-endometrial-and-ovarian-cancers/338586.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of this systematic review?","Question",{"text":113,"@type":114},"It summarizes proposed molecular mechanisms connecting PCOS with endometrial cancer (EC) or ovarian cancer (OVCA). It also identifies reported molecular signatures, biomarkers, and potential drug candidates.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were relevant studies identified and assessed?",{"text":118,"@type":114},"A systematic literature review searched for English studies published from 2010 to December 2022, following PRISMA. Study quality and risk of bias were assessed using QUADAS-2 and Review Manager, with the protocol registered on PROSPERO (CRD42022375461).",{"name":120,"@type":111,"acceptedAnswer":121},"What types of molecular evidence were reported for the PCOS–EC/OVCA link?",{"text":122,"@type":114},"The review reports molecular signatures from genomic, transcriptomic, metabolomic, proteomic, and epigenetic analyses, including overlapping deregulated genes such as BRCA1, MLH1, NQO1, and ESR1, plus serum biomarker signals like IGF1/IGFBP1/SREBP1/visfatin and salusin-β.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338586,1790194465,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Journal of Cellular and Molecular Medicine  \nREVIEW  OPEN ACCESS   \nA Systematic Review of the Molecular Mechanisms Involved in the Association Between PCOS and Endometrial and Ovarian Cancers  \nM. Zanjirband1  | M. H. Nasr-Esfahani1 | N. J. Curtin2 | Y. Drew3 | S. Sharma Saha2 | P. Adibi4 | J. Lunec5   \n1Department of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran | 2Translational and Clinical Research Institute, Newcastle University Cancer Centre, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK | 3BC Cancer Vancouver and University of British Columbia, Vancouver, British Columbia, Canada | 4Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary | 5Biosciences Institute, Newcastle University Cancer Centre, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK  \nCorrespondence: M. Zanjirband ([maryamzanjirband118@gmail.com](maryamzanjirband118@gmail.com))  \nReceived: 18 June 2024 | Revised: 24 November 2024 | Accepted: 10 December 2024  \nFunding: The authors received no specific funding for this work.  \nKeywords: biomarker | EC | molecular signature | OVCA | PCOS  \nABSTRACT  \nPolycystic ovary syndrome (PCOS), a major cause of female infertility, affects 4%–20% of reproductive-age women. Metabolic and hormonal alterations are key features of PCOS, potentially raising the risk of endometrial (EC) and ovarian (OVCA) cancers. This systematic review aims to summarise the proposed molecular mechanisms involved in the association between PCOS and EC or OVCA. This is achieved by conducting a thorough literature review and utilising specific search terms to identify all relevant studies published in English from 2010 to December 2022. PRISMA was followed, and the protocol was registered on PROSPERO (CRD42022375461) . The QUADAS-2 tool and Review Manager Software were employed to evaluate study quality and risk of bias respectively. Forty-five eligible studies were selected with molecular signatures based on genomic, transcriptomic, metabolomic, proteomic and epigenetic analyses. Genes and their products deregulated in EC and/or OVCA were identified, including BRCA1, MLH1, NQO1 and ESR1, which were also deregulated in PCOS. Serum levels of IGF1, IGFBP1, SREBP1 and visfatin in women with PCOS were also identified as potential biomarkers of enhanced EC risk. Salusin-β serum levels in individuals with PCOS were identified as a potential biomarker for increased risk of OVCA. Gene signature–based drug repositioning identified several drug candidates: metformin, fenofibrate, fatostatin, melatonin, resveratrol and quercetin, some already established and prescribed for PCOS. In conclusion, this study provides a strong basis for further research to confirm the identified molecular signatures and associated causal links for potential therapeutic prevention strategies for EC and OVCA in women with PCOS.  \n1 | Introduction  \nPolycystic ovarian syndrome (PCOS) is the most common endocrine-gynaecology disorder with variable prevalence, 4%– 20%. Diagnosis requires the presence oftwo of the following criteria: hyperandrogenism, ovulation dysfunction and polycystic  \novarian morphology, as per the Rotterdam PCOS diagnostic criteria [1] . PCOS is a complex condition with multiple potential contributors, including genetic and epigenetic mechanisms, insulin resistance, hormonal imbalances, inflammation, oxidative stress and obesity, which gradually may lead to cancer over time [2, 3] .  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.  \nJournal of Cellular and Molecular Medicine, 2024; 28:e70","cbCainr6ACQADH2g","https://ap.wps.com/l/cbCainr6ACQADH2g","pdf",578160,14,"English","# Introduction\n## PCOS definition and diagnostic criteria\n## Proposed contributors to cancer risk\n## Epidemiology of EC and OVCA risk in PCOS\n# Methods and quality assessment\n## Literature search scope and selection approach\n## PRISMA and PROSPERO registration\n## QUADAS-2 and risk of bias evaluation\n# Findings: molecular signatures and biomarkers\n## Genomic, transcriptomic, metabolomic, proteomic and epigenetic changes\n## Overlapping deregulated genes across EC/OVCA and PCOS\n## Candidate serum biomarkers for EC and OVCA risk\n# Findings: therapeutic implications\n## Gene signature–based drug repositioning candidates","[{\"question\":\"What is the purpose of this systematic review?\",\"answer\":\"It summarizes proposed molecular mechanisms connecting PCOS with endometrial cancer (EC) or ovarian cancer (OVCA). It also identifies reported molecular signatures, biomarkers, and potential drug candidates.\"},{\"question\":\"How were relevant studies identified and assessed?\",\"answer\":\"A systematic literature review searched for English studies published from 2010 to December 2022, following PRISMA. Study quality and risk of bias were assessed using QUADAS-2 and Review Manager, with the protocol registered on PROSPERO (CRD42022375461).\"},{\"question\":\"What types of molecular evidence were reported for the PCOS–EC/OVCA link?\",\"answer\":\"The review reports molecular signatures from genomic, transcriptomic, metabolomic, proteomic, and epigenetic analyses, including overlapping deregulated genes such as BRCA1, MLH1, NQO1, and ESR1, plus serum biomarker signals like IGF1/IGFBP1/SREBP1/visfatin and salusin-β.\"}]","A Systematic Review of the Molecular Mechanisms Involved in the Association Between PCOS and Endometrial and Ovarian Cancers | PDF",1790024365,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35d1d2ffcca30994fe41ab962285ba1e.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc92e61b6085ebf2344c8971c0d6f5ae.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4fef9b548f88b1758179090f7fc6261.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/475f6f1e3dcf91adb2c1f6571b83e5c7.webp",980,1287]